Case report of a successfully treated gentamicin and ciprofloxacin resistant Serratia marcescens prosthetic joint infection

Ann R Coll Surg Engl. 2014 Nov;96(8):e23-5. doi: 10.1308/003588414X13946184903289.

Abstract

We report the case of an eradicated multiresistant Serratia marcescens prosthetic hip joint infection. It is estimated that enteric Gram-negative organisms account for approximately 8% of prosthetic joint infections. However, the evolving multiresistant strains of organisms being encountered in hospital acquired infections is making eradication increasingly difficult. We describe n our surgical and microbiological approach to this in a complex case.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Arthroplasty, Replacement, Hip / adverse effects
  • Ciprofloxacin / pharmacology
  • Ciprofloxacin / therapeutic use*
  • Gentamicins / pharmacology
  • Gentamicins / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Prosthesis-Related Infections / drug therapy*
  • Prosthesis-Related Infections / microbiology*
  • Serratia Infections / drug therapy*
  • Serratia Infections / microbiology
  • Serratia marcescens / drug effects*
  • Serratia marcescens / isolation & purification*

Substances

  • Anti-Bacterial Agents
  • Gentamicins
  • Ciprofloxacin